{"id":16629,"date":"2026-06-05T01:31:00","date_gmt":"2026-06-04T23:31:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=5300817099aa9ebb91445edad6441c98"},"modified":"2026-06-05T01:31:00","modified_gmt":"2026-06-04T23:31:00","slug":"ocs-investors-have-opportunity-to-join-oculis-holding-ag-fraud-investigation-with-the-schall-law-firm","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=16629","title":{"rendered":"OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm"},"content":{"rendered":"<p>LOS ANGELES--(BUSINESS WIRE)--<a href=\"https:\/\/twitter.com\/search?q=%24OCS&src=ctag\" >$OCS<\/a>--<a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fschallfirm.com%2F&amp;esheet=54547974&amp;newsitemid=20260604062372&amp;lan=en-US&amp;anchor=The+Schall+Law+Firm&amp;index=1&amp;md5=8d4f9e2b5c69b937635f0d0493a41a0d\" rel=\"nofollow\" shape=\"rect\">The Schall Law Firm<\/a>, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Oculis Holding AG (\u201cOculis\u201d or \u201cthe Company\u201d) (NASDAQ: <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FABVX&amp;esheet=54547974&amp;newsitemid=20260604062372&amp;lan=en-US&amp;anchor=OCS&amp;index=2&amp;md5=0b5a0fa5bfc21727c772d23f9a3402cf\" rel=\"nofollow\" shape=\"rect\">OCS<\/a>) for violations of the securities laws.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260604062372\/en\/827144\/5\/Schall-Firm-Logo-640x360.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260604062372\/en\/827144\/22\/Schall-Firm-Logo-640x360.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260604062372\/en\/827144\/5\/Schall-Firm-Logo-640x360.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260604062372\/en\/827144\/21\/Schall-Firm-Logo-640x360.jpg\" \/><\/a><p>\nThe investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Oculis claimed that its Phase 3 DIAMOND trials were \u201cadvancing as planned,\u201d but then announced on May 29, 2026, that both DIAMOND trials failed to meet their primary endpoints. The Company added that based on these results, it would not pursue an FDA filing for its drug candidate.<\/p><p>\nIf you are a shareholder who suffered a loss, <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fschallfirm.com%2Fcases%2Foculis-holding-ag%2F%23case-form&amp;esheet=54547974&amp;newsitemid=20260604062372&amp;lan=en-US&amp;anchor=click+here+to+participate&amp;index=3&amp;md5=8c9479f9d5a417f4036330e6a999289d\" rel=\"nofollow\" shape=\"rect\">click here to participate<\/a>.<\/p><p>\nWe also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fpr.report%2FhApjv-2Z&amp;esheet=54547974&amp;newsitemid=20260604062372&amp;lan=en-US&amp;anchor=www.schallfirm.com&amp;index=4&amp;md5=ab2c07bb2eb068a488cf73beccc7e7c1\" rel=\"nofollow\" shape=\"rect\">www.schallfirm.com<\/a>, or by email at <a  href=\"mailto:bschall@schallfirm.com\" rel=\"nofollow\" shape=\"rect\">bschall@schallfirm.com<\/a>.<\/p><p>\nThe Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.<\/p><p>\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\nThe Schall Law Firm\n<br\/>Brian Schall, Esq.\n<br\/>310-301-3335\n<br\/><a  href=\"mailto:info@schallfirm.com\" rel=\"nofollow\" shape=\"rect\">info@schallfirm.com<\/a><br\/><a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fpr.report%2FApg0Tmvn&amp;esheet=54547974&amp;newsitemid=20260604062372&amp;lan=en-US&amp;anchor=www.schallfirm.com&amp;index=5&amp;md5=09411afa14aa1b4cad52473f7aa79b15\" rel=\"nofollow\" shape=\"rect\">www.schallfirm.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>LOS ANGELES&#8211;(BUSINESS WIRE)&#8211;$OCS&#8211;The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Oculis Holding AG (\u201cOculis\u201d or \u201cthe Company\u201d) (NASDAQ: OCS) for violations of th&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-16629","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/16629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16629"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/16629\/revisions"}],"predecessor-version":[{"id":16630,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/16629\/revisions\/16630"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}